Immix Biopharma, Inc.
IMMXNasdaqHealthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | $20.0M | — | — |
| Operating income | −$30.0M | −$22.7M | −$16.1M | −$8.2M | −$1.4M | −$453,852 |
| Net income | −$29.4M | −$21.6M | −$15.4M | −$8.2M | −$24.4M | −$1.1M |
| Total assets | $104.8M | $22.9M | $19.9M | $14.9M | $18.2M | $539,597 |
| Total liabilities | $11.0M | $9.7M | $3.7M | $1.7M | $202,039 | $5.3M |
| Equity | $93.8M | $13.3M | $16.4M | $13.2M | $18.0M | −$4.7M |
| EPS (diluted) | $-0.89 | $-0.76 | $-0.89 | $-0.59 | $-6.64 | — |
| Shares out. | 27.7M | 26.4M | 13.9M | 13.9M | 13.2M | 3.4M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- —
- Return on equity
- −31.4%
- Return on assets
- −28.1%
- Return on capital (ROCE)
- −31.6%
- Liabilities / assets
- 10.5%
- Debt / equity
- 0.12×
- Book value / share
- $3.38
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 9.45safe
- Accruals / assets
- −5.3%clean
- Piotroski F-Score
- 4/7mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 warning● 3 good- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Janus Henderson Group PlcPassive (13G)May 15, 2026
- Millennium Management LlcPassive (13G)May 4, 2026
- Saturn V Capital Management LpPassive (13G)Feb 17, 2026
- Hirschman OrinPassive (13G)Jan 29, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 3.2M | 4.2 | +6.6% |
| Apr 30, 2026 | 3.0M | 4.4 | +1.9% |
| Apr 15, 2026 | 3.0M | 4.9 | -4.9% |
| Mar 31, 2026 | 3.1M | 3.0 | +3.9% |
| Mar 13, 2026 | 3.0M | 4.6 | +1.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Shareholder voteMay 29, 2026
- Other material eventMay 21, 2026
- Regulation FD disclosure · Other material eventMay 21, 2026
- Regulation FD disclosure · Other material eventMar 30, 2026
- Entered a material agreementMar 25, 2026
- Entered a material agreementDec 8, 2025
- Regulation FD disclosure · Other material eventDec 8, 2025
- Other material eventNov 26, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.